药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tolazamide
Cortivazol
The metabolism of Saquinavir can be decreased when combined with Cortivazol.
Tolazamide
Cortisone acetate
The metabolism of Saquinavir can be decreased when combined with Cortisone acetate.
Tolazamide
Corticotropin
The metabolism of Saquinavir can be decreased when combined with Corticotropin.
Tolazamide
Dexamethasone
The metabolism of Saquinavir can be decreased when combined with Dexamethasone.
Tolazamide
Sodium zirconium cyclosilicate
Sodium zirconium cyclosilicate can cause a decrease in the absorption of Saquinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tolazamide
Salvianolic acid A
Salvianolic acid A can cause a decrease in the absorption of Saquinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tolazamide
Aluminium phosphate
Aluminium phosphate can cause a decrease in the absorption of Saquinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tolazamide
Calcium silicate
Calcium silicate can cause a decrease in the absorption of Saquinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tolazamide
Aloglutamol
Aloglutamol can cause a decrease in the absorption of Saquinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tolazamide
Aluminium glycinate
Aluminium glycinate can cause a decrease in the absorption of Saquinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tolazamide
Almasilate
Almasilate can cause a decrease in the absorption of Saquinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tolazamide
Magnesium peroxide
Magnesium peroxide can cause a decrease in the absorption of Saquinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tolazamide
Hydrotalcite
Hydrotalcite can cause a decrease in the absorption of Saquinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tolazamide
Aluminium acetoacetate
Aluminium acetoacetate can cause a decrease in the absorption of Saquinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tolazamide
Magnesium silicate
Magnesium silicate can cause a decrease in the absorption of Saquinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tolazamide
Bismuth subnitrate
Bismuth subnitrate can cause a decrease in the absorption of Saquinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tolazamide
Magnesium carbonate
Magnesium carbonate can cause a decrease in the absorption of Saquinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tolazamide
Magnesium trisilicate
Magnesium trisilicate can cause a decrease in the absorption of Saquinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tolazamide
Magnesium hydroxide
Magnesium hydroxide can cause a decrease in the absorption of Saquinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tolazamide
Magaldrate
Magaldrate can cause a decrease in the absorption of Saquinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.